TScan Therapeutics (TCRX) Insider Trading & Ownership $1.51 +0.04 (+2.72%) Closing price 07/3/2025 03:55 PM EasternExtended Trading$1.51 0.00 (0.00%) As of 07/3/2025 04:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock TScan Therapeutics (NASDAQ:TCRX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.35%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$3.19MNumber OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$951.89K Get TCRX Insider Trade Alerts Want to know when executives and insiders are buying or selling TScan Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address TCRX Insider Buying and Selling by Quarter TScan Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/20/2025Lynx1 Capital Management LpMajor ShareholderBuy1,200,000$1.20$1,440,000.00 5/19/2025Lynx1 Capital Management LpMajor ShareholderBuy1,388,794$1.20$1,666,552.80 11/15/2024Lynx1 Capital Management LpMajor ShareholderBuy947$4.34$4,109.98 9/23/2024Barbara KlenckeDirectorBuy5,000$5.29$26,450.00 8/26/2024Barbara KlenckeDirectorBuy5,000$5.53$27,650.00 8/23/2024Barbara KlenckeDirectorBuy5,000$5.69$28,450.00 8/23/2024Zoran ZdraveskiInsiderSell164,686$5.78$951,885.08 (Data available from 1/1/2013 forward) TCRX Insider Trading Activity - Frequently Asked Questions Who is on TScan Therapeutics' Insider Roster? The list of insiders at TScan Therapeutics includes Barbara Klencke, Brian M Silver, Lynx1 Capital Management Lp, Timothy J Barberich, and Zoran Zdraveski. Learn more on insiders at TCRX. What percentage of TScan Therapeutics stock is owned by insiders? 4.35% of TScan Therapeutics stock is owned by insiders. Learn more on TCRX's insider holdings. Which TScan Therapeutics insiders have been buying company stock? The following insiders have purchased TCRX shares in the last 24 months: Barbara Klencke ($107,950.00), Lynx1 Capital Management Lp ($3,110,662.78), and Timothy J Barberich ($140,978.70). How much insider buying is happening at TScan Therapeutics? Insiders have purchased a total of 2,638,571 TCRX shares in the last 24 months for a total of $3,359,591.48 bought. Which TScan Therapeutics insiders have been selling company stock? The following insider sold TCRX shares in the last 24 months: Zoran Zdraveski ($951,885.08). How much insider selling is happening at TScan Therapeutics? Insiders have sold a total of 164,686 TScan Therapeutics shares in the last 24 months for a total of $951,885.08 sold. More Insider Trading Tools from MarketBeat Related Companies OLMA Insider Ownership AURA Insider Ownership ATXS Insider Ownership LFCR Insider Ownership BNTC Insider Ownership AVIR Insider Ownership AARD Insider Ownership OCGN Insider Ownership GOSS Insider Ownership ALT Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insider Selling at NVIDIA Could Turn Into an Opportunity The Top Insider Sells From Q2: Buy, Sell, or Hold?3 Hot Trades for Insiders, But Are They Good Buys for Investors?Insiders Chase Income and Stability in American Tower—Here’s Why3 Tech Stocks With High and Rising Institutional Interest This page (NASDAQ:TCRX) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredThe mainstream media is wrong about AI — againThe mainstream media got it wrong … yet again. AI has recently turned the tech world on its head. And th...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TScan Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TScan Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
